UnitedHealth Group (UNH) has long been one of the biggest names in the health insurance and managed care sector, wearing many hats through its insurance operations and fast-growing healthcare services arm. For years, it was the kind of stock investors could simply buy and let time do the heavy lifting. Then the tide turned. The past couple of years threw more than a few curveballs, with a sharp rise in Medicare Advantage costs and mounting pressure dragging the shares lower. Although the stock has staged an encouraging comeback in 2026, many investors are still waiting to see if this turnaround has real legs.
That's why July 16 deserves a big circle on the calendar. UnitedHealth is set to report its second-quarter earnings before the market opens, and Wall Street will be watching closely for signs that the recovery is staying on track.
Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, **** ysis, and headlines.
The company heads into the release with the wind at its back. In the first quarter, it topped Wall Street's expectations, improved its medical care ratio to 83.9%, raised its full-year earnings guidance, and expressed confidence that its efforts to simplify operations and strengthen execution are beginning to pay off.
With optimism building ahead of the earnings release, let's take a closer look at whether UNH stock still has room to run.